Mankind Pharma Placement - Well Flagged, past Deals Have Done Well but Its Expensive
ChrysCap is looking to raise around US$295m via selling a 2.8% stake in Mankind Pharma. In this note, we talk about the deal dynamics.
504 Views
𝛼SK or SearchENTITY
Alkemy Capital Investments (ALK LN)
Alkemy Capital Investments (ALK LN)
8
Analysis
Financials • United Kingdom
Alkemy Capital Investments Plc is an investment vehicle focused on the critical minerals sector, particularly battery materials like lithium, essential for the global energy transition. The company is involved in developing and investing in projects for lithium hydroxide processing in Teesside, UK, and a lithium ore enrichment facility in Port Hedland, Australia. It was founded in 2021 and is headquartered in London, United Kingdom.
morex